Study of Efficacy and Safety of CJM112 in Patients With Moderate to Severe Inflammatory Acne
Clinical trial NCT02998671 · COMPLETED
Trial details
- NCT number
- NCT02998671
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2018-08-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.